20
Participants
Start Date
April 1, 2021
Primary Completion Date
December 31, 2024
Study Completion Date
December 31, 2025
VR-treatment
The participants will be randomized either to group which receives the VR-intervention immediately (A) or to the waitlist control group (B). After the baseline assessment, the participants in the group A participate VR-intervention lasting for 8 weeks, and the participants in the group B will receive 8 weeks waitlist period. After the 8 weeks, the groups switch their places
Treatment as usual
The participants will be randomized either to group which receives the VR-intervention immediately (A) or to the waitlist control group (B). After the baseline assessment, the participants in the group A participate VR-intervention lasting for 8 weeks, and the participants in the group B will receive 8 weeks waitlist period. After the 8 weeks, the groups switch their places
Collaborators (1)
Peili Vision Oy
UNKNOWN
Verve Oulu
UNKNOWN
City of Oulu
UNKNOWN
University of Oulu
OTHER